|
|
||||||||
Published online before print September 15, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Departments of Clinical Neurosciences, Applied Immunology, Karolinska Hospital, and
Medicine, Rheumatology Unit, Karolinska Institutet at Karolinska Hospital, Stockholm, Sweden
1 Correspondence: Applied Immunology Unit, CMM L8:04, Karolinska Sjukhuset, S-171 76 Stockholm, Sweden. E-mail: Asa.Andersson{at}cmm.ki.se
Rodents typically demonstrate strain-specific susceptibilities to induced autoimmune models such as experimental arthritis and encephalomyelitis. A common feature of the local pathology of these diseases is an extensive infiltration of activated macrophages (M
). Different functional activation states can be induced in M
during innate immune activation, and it is this differential activation that might be important in susceptibility/resistance to induction or perpetuation of autoimmunity. In this study, we present an extensive, comparative analysis of the activation phenotypes of M
derived from autoimmune-susceptible and autoimmune-resistant rat strains to describe a cellular phenotype that defines the disease phenotype. We included investigation of receptor function, intracellular signaling pathways, cytokines, and other soluble mediators released after activation of cells using a panel of stimuli embracing many activation routes. We report that activation of M
from the autoimmune-susceptible strain was associated with alternative activation indicated by induction of arginase activity, a lower production of classical proinflammatory mediators, and a high production of interleukin (IL)-23, and M
from the autoimmune-resistant strains were associated with a higher production of proinflammatory mediators, a classical activation phenotype, and preferential induction of IL-12. These M
phenotypes thus reflect disparate, genetic cellular programs that define autoimmune susceptibility.
Key Words: cytokine macrophage activation autoimmunity
This article has been cited by other articles:
![]() |
A. Andersson, R. Covacu, D. Sunnemark, A. I. Danilov, A. Dal Bianco, M. Khademi, E. Wallstrom, A. Lobell, L. Brundin, H. Lassmann, et al. Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis J. Leukoc. Biol., November 1, 2008; 84(5): 1248 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bozza, T. Zelante, S. Moretti, P. Bonifazi, A. DeLuca, C. D'Angelo, G. Giovannini, C. Garlanda, L. Boon, F. Bistoni, et al. Lack of Toll IL-1R8 Exacerbates Th17 Cell Responses in Fungal Infection J. Immunol., March 15, 2008; 180(6): 4022 - 4031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Butchar, M. V. S. Rajaram, L. P. Ganesan, K. V. L. Parsa, C. D. Clay, L. S. Schlesinger, and S. Tridandapani Francisella tularensis Induces IL-23 Production in Human Monocytes J. Immunol., April 1, 2007; 178(7): 4445 - 4454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |